Day: February 5, 2021

Rhode Island cannabis companies have a new regulatory chief to oversee the medical marijuana market. Rhode Island medical marijuana program gets new regulatory czar is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs Read More: Rhode Island medical marijuana program gets newContinue Reading

Harborside, a California cannabis dispensary, appealed the Tax Court’s decision of tax deficiencies totaling over $29 million dollars for the periods between 2007 through 2012. Harborside’s tax liability stems from the IRS’s denial of deductions under IRC §280E and the disallowances of cost of goods sold reported on Harborside’s taxContinue Reading

CONTACT INFORMATION: Custom Cones USA Harrison Bard 970-373-3592 harrison@customconesusa.com RELEASE DATE: February 5, 2021 “Pre-Roll Experts” create a one-stop shop for cannabis brands offering pre-rolls. Dateline: [FIFE, WASHINGTON, February 2021] — In an ongoing effort to offer cannabis brands everything needed to launch or expand their pre-roll business, Custom ConesContinue Reading

The California Department of Public Health on Thursday issued an updated COVID-19 vaccination policy clarifying that cannabis industry employees are classified as health-care workers and therefore are immediately eligible to receive the vaccine. According to the bulletin, “cannabis industry employees are included in Phase 1a for medicinal cannabis and PhaseContinue Reading

Michigan’s marijuana regulatory agency is warning local cannabis companies that fraudsters are masquerading as regulators and industry executives in a bid to trick employees into sending money or security information about their businesses. One business lost more than $100,000 because of the scam, the Michigan Marijuana Regulatory Agency (MRA) notedContinue Reading

Jazz Pharmaceuticals’ planned $7.2 billion takeover of United Kingdom-based GW Pharmaceuticals could kick off a wave of deal-making between pharma and medical cannabis companies, analysts and industry sources say. But rather than all cannabis producers benefiting, only businesses that have marketable intellectual property and an established foothold in the medicalContinue Reading